ZLN005 protects neonatal cardiomyocytes from high glucose-induced cell injury.
ZLN005 promotes SIRT1 expression in cardiomyocytes under normal and high glucose conditions.
ZLN005 restores high glucose-suppressed autophagy via a SIRT1-mediated pathway.